Literature DB >> 31656818

Diagnosis of hemoglobinopathy and β-thalassemia by 21-Tesla Fourier transform ion cyclotron resonance mass spectrometry.

Jae-Seok Kim1, Hyun Sik Kim2.   

Abstract

Entities:  

Year:  2019        PMID： 31656818      PMCID： PMC6789315          DOI： 10.21037/atm.2019.07.97

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  12 in total

Review 1.  Fourier transform ion cyclotron resonance mass spectrometry: a primer.

Authors:  A G Marshall; C L Hendrickson; G S Jackson
Journal:  Mass Spectrom Rev       Date:  1998 Jan-Feb       Impact factor: 10.946

2.  21 Tesla Fourier Transform Ion Cyclotron Resonance Mass Spectrometer: A National Resource for Ultrahigh Resolution Mass Analysis.

Authors:  Christopher L Hendrickson; John P Quinn; Nathan K Kaiser; Donald F Smith; Greg T Blakney; Tong Chen; Alan G Marshall; Chad R Weisbrod; Steven C Beu
Journal:  J Am Soc Mass Spectrom       Date:  2015-06-20       Impact factor: 3.109

3.  Top-down proteomics and direct surface sampling of neonatal dried blood spots: diagnosis of unknown hemoglobin variants.

Authors:  Rebecca L Edwards; Paul Griffiths; Josephine Bunch; Helen J Cooper
Journal:  J Am Soc Mass Spectrom       Date:  2012-09-20       Impact factor: 3.109

Review 4.  Thalassemia in the laboratory: pearls, pitfalls, and promises.

Authors:  Gunay Aliyeva; Chingiz Asadov; Tahira Mammadova; Surmaya Gafarova; Eldar Abdulalimov
Journal:  Clin Chem Lab Med       Date:  2018-12-19       Impact factor: 3.694

5.  21 Tesla FT-ICR Mass Spectrometer for Ultrahigh-Resolution Analysis of Complex Organic Mixtures.

Authors:  Donald F Smith; David C Podgorski; Ryan P Rodgers; Greg T Blakney; Christopher L Hendrickson
Journal:  Anal Chem       Date:  2018-01-05       Impact factor: 6.986

6.  Diagnosis of Hemoglobinopathy and β-Thalassemia by 21 Tesla Fourier Transform Ion Cyclotron Resonance Mass Spectrometry and Tandem Mass Spectrometry of Hemoglobin from Blood.

Authors:  Lidong He; Alan L Rockwood; Archana M Agarwal; Lissa C Anderson; Chad R Weisbrod; Christopher L Hendrickson; Alan G Marshall
Journal:  Clin Chem       Date:  2019-04-30       Impact factor: 8.327

7.  Analysis of cancer cell lipids using matrix-assisted laser desorption/ionization 15-T Fourier transform ion cyclotron resonance mass spectrometry.

Authors:  Hyo-Jik Yang; Kyu Hwan Park; Dong Wan Lim; Hyun Sik Kim; Jeongkwon Kim
Journal:  Rapid Commun Mass Spectrom       Date:  2012-03-30       Impact factor: 2.419

8.  Clarification of a peak at m/z 1634 from tryptically digested cytochrome c.

Authors:  Seongjae Shin; Hyo-Jik Yang; Jae-hyung Kim; Jinhee Kim; Ji-hye Lee; Kyu Hwan Park; Hyun Sik Kim; Jeongkwon Kim
Journal:  J Mass Spectrom       Date:  2012-12       Impact factor: 1.982

Review 9.  Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

Authors:  Barbara P Yawn; George R Buchanan; Araba N Afenyi-Annan; Samir K Ballas; Kathryn L Hassell; Andra H James; Lanetta Jordan; Sophie M Lanzkron; Richard Lottenberg; William J Savage; Paula J Tanabe; Russell E Ware; M Hassan Murad; Jonathan C Goldsmith; Eduardo Ortiz; Robinson Fulwood; Ann Horton; Joylene John-Sowah
Journal:  JAMA       Date:  2014-09-10       Impact factor: 56.272

Review 10.  β-Thalassemia.

Authors:  Raffaella Origa
Journal:  Genet Med       Date:  2016-11-03       Impact factor: 8.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.